Elanco Animal Health Inc — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$4.71B
Cost of Revenue
$2.12B
Gross Profit
$2.59B
R&D
$368M
SG&A
$1.43B
D&A
$680M
EBITDA
$680M
Interest Expense
—
Interest Income
$43M
Pretax Income
$-224M
Tax Provision
$8M
Net Income
$-232M
Gross Margin
55.0%
Net Margin
-4.9%
Effective Tax Rate
-3.6%
Deferred Tax Assets
$456M
Deferred Tax Liabilities
$382M
DTA Valuation Allowance
$246M
Tax Credit Carryforwards
$45M
NOL Carryforwards
$153M
ETR (Continuing Operations)
-3.5%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-0.9%
Operating Lease Cost
$58M
Pension Net Periodic Cost
—
Revenue YoY Variation
6.2%